Centbutindole vs trifluoperazine: a double-blind controlled clinical study in acute schizophrenia.
J Postgrad Med
;
1989 Jan; 35(1): 3-8
Article
in English
| IMSEAR
| ID: sea-117542
ABSTRACT
Twenty-nine acute schizophrenic patients were treated under double-blind conditions for six weeks with either centbutindole in a dose range of 3 mg/day to 4.5 mg/day or trifluoperazine in the dose range of 15 mg/day to 22.5 mg/day. Both drugs produced a significant improvement in initial psychopathology. No significant differences were demonstrated between the two treatment conditions.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Pyrazines
/
Schizophrenia
/
Trifluoperazine
/
Female
/
Humans
/
Male
/
Random Allocation
/
Double-Blind Method
/
Clinical Trials as Topic
/
Adult
Type of study:
Controlled clinical trial
Language:
English
Journal:
J Postgrad Med
Year:
1989
Type:
Article
Similar
MEDLINE
...
LILACS
LIS